Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

JAMA Neurology Author Interviews - Un pódcast de JAMA Network - Lunes

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

Visit the podcast's native language site